Application Value of Antimicrobial Peptides in Gastrointestinal Tumors
Open Access
- 24 November 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (23) , 16718
Abstract
Gastrointestinal cancer is a common clinical malignant tumor disease that seriously endangers human health and lacks effective treatment methods. As part of the innate immune defense of many organisms, antimicrobial peptides not only have broad-spectrum antibacterial activity but also can specifically kill tumor cells. The positive charge of antimicrobial peptides under neutral conditions determines their high selectivity to tumor cells. In addition, antimicrobial peptides also have unique anticancer mechanisms, such as inducing apoptosis, autophagy, cell cycle arrest, membrane destruction, and inhibition of metastasis, which highlights the low drug resistance and high specificity of antimicrobial peptides. In this review, we summarize the related studies on antimicrobial peptides in the treatment of digestive tract tumors, mainly oral cancer, esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, and colorectal cancer. This paper describes the therapeutic advantages of antimicrobial peptides due to their unique anticancer mechanisms. The length, net charge, and secondary structure of antimicrobial peptides can be modified by design or modification to further enhance their anticancer effects. In summary, as an emerging cancer treatment drug, antimicrobial peptides need to be further studied to realize their application in gastrointestinal cancer diseases.Keywords
Funding Information
- National Natural Science Foundation of China (31860607)
This publication has 187 references indexed in Scilit:
- FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer CellsPLOS ONE, 2013
- Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptidesFrontiers in Microbiology, 2013
- Anti-Tumor Effects of the Peptide TMTP1-GG-D(KLAKLAK)2 on Highly Metastatic CancersPLOS ONE, 2012
- Cancer and Radiation Therapy: Current Advances and Future DirectionsInternational Journal of Medical Sciences, 2012
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cellsBMC Cancer, 2009
- Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsBMC Urology, 2008
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Microtubules Support Production of Starvation-induced Autophagosomes but Not Their Targeting and Fusion with LysosomesJournal of Biological Chemistry, 2006
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005